CPX-351 vs 7+3: Cardiotoxicity
Cardiotoxicity of CPX-351 vs 7+3 in Previously Untreated High-Risk or Secondary AML: Post Hoc Analysis of a Pivotal Phase III Trial

Released: June 09, 2023

Activity

Progress
1
Course Completed